San Diego Heart Failure Symposiums
Advances in Treating Hyperlipidemia: What Are the Results of Trials with PCSK9 Inhibitors and Icosapent Ethyl? What Are the Benefits of Bempedoic Acid and Inclisiran?
By
26th Annual San Diego Heart Failure Symposium
FEATURING
Pam Taub
By
26th Annual San Diego Heart Failure Symposium
FEATURING
Pam Taub
Comments 4
Login to view comments.
Click here to Login